Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow

Aims. To assess the development of medical care and pharmacological treatment at Endocrine Research Centre (ERC), Moscow, forthe period of 2010-2011 years.Materials and Methods. We analyzed files of 100 patients with type 2 diabetes mellitus (T2DM), who underwent hospitalization to ERCafter Januar...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ivan Ivanovich Dedov, Marina Vladimirovna Shestakova, Evgeny Vladimirovich Tarasov, Ekaterina Alekseevna Shestakova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2012
Materias:	diabetes mellitus type 2 expenditures length of hospital stay morbidity Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/3c9c8d064e6644b0ab6211891b32e86a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3c9c8d064e6644b0ab6211891b32e86a
record_format	dspace
spelling	oai:doaj.org-article:3c9c8d064e6644b0ab6211891b32e86a2021-11-14T09:00:17ZPharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow2072-03512072-037810.14341/2072-0351-6093https://doaj.org/article/3c9c8d064e6644b0ab6211891b32e86a2012-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6093https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aims. To assess the development of medical care and pharmacological treatment at Endocrine Research Centre (ERC), Moscow, forthe period of 2010-2011 years.Materials and Methods. We analyzed files of 100 patients with type 2 diabetes mellitus (T2DM), who underwent hospitalization to ERCafter January 1, 2010. Key parameters were assessed by means of a study chart, applied for every patient file. Mean values, medians,fractions and confidence intervals (CI) were calculated for studied parameters. Various methods of parametric and non-parametricstatistics were used for comparison of acquired values. Results. Files of 100 patients with T2DM, hospitalized to Endocrinology Research Centre, were analyzed to obtain clinical characteristicsand evaluate initial (prior to hospitalization) and optimized (after hospitalization) therapeutic schemes, as well as spendingpatterns. Mean patient age exceeded 63 years, mean duration period of T2DM was greater than 14.4 years. 86% of patients weredecompensated for glycemic metabolism. 8% were diagnosed with less than 3 diabetes complications, 66% were found to have from 3to 6 complications. Almost all studied cases (98%) featured elevated blood pressure, 63% - diabetic retinopathy on different stages,59% - IHD, 51% - cataract, 49% - CKD. Lower limb angiopathy was found in 30% of cases, diabetic foot syndrome - in 15%.2 patients lost their vision due to diabetic complications and 3 patients experienced lower limb amputation. Arterial hypertension wascompensated in 14 cases from total of 98.Correction of therapy decreased fraction of patients on oral hypoglycemic agents and intermediate acting insulin (NPH), while prescriptionfrequency of short acting insulin and rapid acting human insulin analogues (as well as long acting analogues) showed oppositetrend. Optimization of therapy also included prescription of hypolipidemic drugs for majority of patients, as well as various agents forcorrection of coagulation abnormalities, treatment for CVD and other complications of T2DM.Due to described measures cost of per day treatment for 100 patients increased 2.28 times: from 8 982 RUB to 20 440 RUB (averagecost per day increased from 89.8 RUB to 204.1 RUB).Following the correction, fraction of patients with fasting glycemia 9.0 mmol/l dropped from 37% to 9%, and that with postprandial glycemia >10.0 mmol/l - from 27% to 1%.Mean fasting glycemia level decreased from 8.6 mmol/l to 6.8 mmol/l.Conducted analysis shows that prime expenditures (more that 36% from total cost structure) were associated with hospital stay (includingintensive care unit). Conclusion. Considering expanding nature of DM epidemic, there is an urgent need for effective healthcare management and preventionof severe cardiovascular complications. Priority should be established on balancing efficiency of hypoglycemic agents with theirsafety for short- and long-term prognosis.Ivan Ivanovich DedovMarina Vladimirovna ShestakovaEvgeny Vladimirovich TarasovEkaterina Alekseevna ShestakovaEndocrinology Research Centrearticlediabetes mellitus type 2expenditureslength of hospital staymorbidityNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 15, Iss 3, Pp 101-109 (2012)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus type 2 expenditures length of hospital stay morbidity Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus type 2 expenditures length of hospital stay morbidity Nutritional diseases. Deficiency diseases RC620-627 Ivan Ivanovich Dedov Marina Vladimirovna Shestakova Evgeny Vladimirovich Tarasov Ekaterina Alekseevna Shestakova Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow
description	Aims. To assess the development of medical care and pharmacological treatment at Endocrine Research Centre (ERC), Moscow, forthe period of 2010-2011 years.Materials and Methods. We analyzed files of 100 patients with type 2 diabetes mellitus (T2DM), who underwent hospitalization to ERCafter January 1, 2010. Key parameters were assessed by means of a study chart, applied for every patient file. Mean values, medians,fractions and confidence intervals (CI) were calculated for studied parameters. Various methods of parametric and non-parametricstatistics were used for comparison of acquired values. Results. Files of 100 patients with T2DM, hospitalized to Endocrinology Research Centre, were analyzed to obtain clinical characteristicsand evaluate initial (prior to hospitalization) and optimized (after hospitalization) therapeutic schemes, as well as spendingpatterns. Mean patient age exceeded 63 years, mean duration period of T2DM was greater than 14.4 years. 86% of patients weredecompensated for glycemic metabolism. 8% were diagnosed with less than 3 diabetes complications, 66% were found to have from 3to 6 complications. Almost all studied cases (98%) featured elevated blood pressure, 63% - diabetic retinopathy on different stages,59% - IHD, 51% - cataract, 49% - CKD. Lower limb angiopathy was found in 30% of cases, diabetic foot syndrome - in 15%.2 patients lost their vision due to diabetic complications and 3 patients experienced lower limb amputation. Arterial hypertension wascompensated in 14 cases from total of 98.Correction of therapy decreased fraction of patients on oral hypoglycemic agents and intermediate acting insulin (NPH), while prescriptionfrequency of short acting insulin and rapid acting human insulin analogues (as well as long acting analogues) showed oppositetrend. Optimization of therapy also included prescription of hypolipidemic drugs for majority of patients, as well as various agents forcorrection of coagulation abnormalities, treatment for CVD and other complications of T2DM.Due to described measures cost of per day treatment for 100 patients increased 2.28 times: from 8 982 RUB to 20 440 RUB (averagecost per day increased from 89.8 RUB to 204.1 RUB).Following the correction, fraction of patients with fasting glycemia 9.0 mmol/l dropped from 37% to 9%, and that with postprandial glycemia >10.0 mmol/l - from 27% to 1%.Mean fasting glycemia level decreased from 8.6 mmol/l to 6.8 mmol/l.Conducted analysis shows that prime expenditures (more that 36% from total cost structure) were associated with hospital stay (includingintensive care unit). Conclusion. Considering expanding nature of DM epidemic, there is an urgent need for effective healthcare management and preventionof severe cardiovascular complications. Priority should be established on balancing efficiency of hypoglycemic agents with theirsafety for short- and long-term prognosis.
format	article
author	Ivan Ivanovich Dedov Marina Vladimirovna Shestakova Evgeny Vladimirovich Tarasov Ekaterina Alekseevna Shestakova
author_facet	Ivan Ivanovich Dedov Marina Vladimirovna Shestakova Evgeny Vladimirovich Tarasov Ekaterina Alekseevna Shestakova
author_sort	Ivan Ivanovich Dedov
title	Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow
title_short	Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow
title_full	Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow
title_fullStr	Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow
title_full_unstemmed	Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow
title_sort	pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of endocrinology research centre, moscow
publisher	Endocrinology Research Centre
publishDate	2012
url	https://doaj.org/article/3c9c8d064e6644b0ab6211891b32e86a
work_keys_str_mv	AT ivanivanovichdedov pharmacoeconomicassessmentoftype2diabetesmellituscareonthebaseofendocrinologyresearchcentremoscow AT marinavladimirovnashestakova pharmacoeconomicassessmentoftype2diabetesmellituscareonthebaseofendocrinologyresearchcentremoscow AT evgenyvladimirovichtarasov pharmacoeconomicassessmentoftype2diabetesmellituscareonthebaseofendocrinologyresearchcentremoscow AT ekaterinaalekseevnashestakova pharmacoeconomicassessmentoftype2diabetesmellituscareonthebaseofendocrinologyresearchcentremoscow
_version_	1718429577308536832

Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow

Ejemplares similares